China · 
Who invested in Shanghai Cell Therapy?
Shanghai Cell Therapy's investors include Legend Capital and China Industrial Asset Management.
2019
$40MSeries C$136MSeries CChina · Series C startup
Who invested in Shanghai Cell Therapy
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$176Mraised across 2 rounds since 2018, from 2 sources
$40MSeries C$136MSeries C
- Latest round
- Series C, $136MDec 2018
- Step-upi
- 3.4×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $40M Nov 2018
- Biggest round
- $136M Series C · Dec 2018
The rounds
- Dec 2018
- Nov 2018
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
China Industrial Asset ManagementCompany1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Shanghai Cell Therapy
How much has Shanghai Cell Therapy raised?
Shanghai Cell Therapy has raised $176M across 2 rounds since 2018.
When did Shanghai Cell Therapy last raise?
Shanghai Cell Therapy's most recent round was a Series C of $136M in Dec 2018.
What was Shanghai Cell Therapy's biggest round?
Its most recent round, $136M in Dec 2018, is also its largest on record.
Who backed Shanghai Cell Therapy first?
Shanghai Cell Therapy's first round on record, in Nov 2018, was backed by China Industrial Asset Management.
What stage is Shanghai Cell Therapy at?
Shanghai Cell Therapy's latest named round is a Series C, in Dec 2018.
Where is Shanghai Cell Therapy based?
Shanghai Cell Therapy is based in China.
Companies like Shanghai Cell Therapy
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.